219 related articles for article (PubMed ID: 25061101)
1. Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.
Sharma A; Janocha AJ; Hill BT; Smith MR; Erzurum SC; Almasan A
Mol Cancer Res; 2014 Sep; 12(9):1205-15. PubMed ID: 25061101
[TBL] [Abstract][Full Text] [Related]
2. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Robitaille AM; Christen S; Shimobayashi M; Cornu M; Fava LL; Moes S; Prescianotto-Baschong C; Sauer U; Jenoe P; Hall MN
Science; 2013 Mar; 339(6125):1320-3. PubMed ID: 23429704
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.
Ben-Sahra I; Howell JJ; Asara JM; Manning BD
Science; 2013 Mar; 339(6125):1323-8. PubMed ID: 23429703
[TBL] [Abstract][Full Text] [Related]
4. Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
Hirashita Y; Tsukamoto Y; Yanagihara K; Fumoto S; Hijiya N; Nakada C; Uchida T; Matsuura K; Kodama M; Okimoto T; Daa T; Seike M; Iha H; Shirao K; Murakami K; Moriyama M
Cancer Sci; 2016 Dec; 107(12):1919-1928. PubMed ID: 27699948
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.
Nagamori S; Wiriyasermkul P; Okuda S; Kojima N; Hari Y; Kiyonaka S; Mori Y; Tominaga H; Ohgaki R; Kanai Y
Amino Acids; 2016 Apr; 48(4):1045-1058. PubMed ID: 26724922
[TBL] [Abstract][Full Text] [Related]
6. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation.
Hong S; Zhao B; Lombard DB; Fingar DC; Inoki K
J Biol Chem; 2014 May; 289(19):13132-41. PubMed ID: 24652283
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab stimulation of ribosomal protein S6 kinase 1 (S6K1) predicts de novo trastuzumab resistance.
Huynh FC; Nguyen D; Jones FE
Biochem Biophys Res Commun; 2017 Jan; 483(1):739-744. PubMed ID: 27993682
[TBL] [Abstract][Full Text] [Related]
10. Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation.
Huck B; Duss S; Hausser A; Olayioye MA
J Biol Chem; 2014 Feb; 289(6):3138-47. PubMed ID: 24337579
[TBL] [Abstract][Full Text] [Related]
11. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
[TBL] [Abstract][Full Text] [Related]
13. Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism.
Schriever SC; Deutsch MJ; Adamski J; Roscher AA; Ensenauer R
J Nutr Biochem; 2013 May; 24(5):824-31. PubMed ID: 22898570
[TBL] [Abstract][Full Text] [Related]
14. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
15. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
16. A conserved role of IQGAP1 in regulating TOR complex 1.
Tekletsadik YK; Sonn R; Osman MA
J Cell Sci; 2012 Apr; 125(Pt 8):2041-52. PubMed ID: 22328503
[TBL] [Abstract][Full Text] [Related]
17. Key Markers of mTORC1-Dependent and mTORC1-Independent Signaling Pathways Regulating Protein Synthesis in Rat Soleus Muscle During Early Stages of Hindlimb Unloading.
Mirzoev T; Tyganov S; Vilchinskaya N; Lomonosova Y; Shenkman B
Cell Physiol Biochem; 2016; 39(3):1011-20. PubMed ID: 27536969
[TBL] [Abstract][Full Text] [Related]
18. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.
Zhang H; Berel D; Wang Y; Li P; Bhowmick NA; Figlin RA; Kim HL
PLoS One; 2013; 8(1):e54918. PubMed ID: 23349989
[TBL] [Abstract][Full Text] [Related]
19. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
[TBL] [Abstract][Full Text] [Related]
20. S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
Ben-Hur V; Denichenko P; Siegfried Z; Maimon A; Krainer A; Davidson B; Karni R
Cell Rep; 2013 Jan; 3(1):103-15. PubMed ID: 23273915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
